Table 1 Patients’ characteristics and results
Case | At diagnosis | At auto-PBSCT | Complications | Survival | Survival status | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | Gender | IPI | Stage | Extranodal lesion | HPS | Initial treatment | CNS prophylaxis | Year | Months from diagnosis | Disease status | High-dose chemotherapy | months from auto-PBSCT | |||
1 | 68 | M | High | IV | Lung, BM | No | R-THP-COP | No | 2012 | 7.1 | CR | Carboplatin+ Ara-C + VP16 | 12 | Alive | |
2 | 53 | F | High | IV | CNS, Spleen, BM | Yes | R-CHOP | Yes | 2012 | 6.8 | CR | R-MCEC | LON | 16 | Alive |
3 | 43 | M | High | IV | Lung, Spleen, BM | Yes | R-CHOP | Yes | 2010 | 5.6 | CR | R-MCEC | Heart failure LON | 43 | Alive |
4 | 68 | M | High-I | IV | Lung | No | R-THP-COP | No | 2008 | 8.0 | CR | Ara-C + L-PAM | 70 | Alive | |
5 | 61 | M | High | IV | Liver, Spleen, BM | No | R-CHOP | No | 2005 | 7.4 | CR | R-MCEC | Secondary MDS LON | 96 | Alive |
6 | 62 | M | High | IV | Liver, Spleen, BM | Yes | R-CHOP | No | 2005 | 5.8 | CR | R-MCEC | LON | 99 | Alive |
